Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Lymphoma Clinical Research Mentoring Program (LCRMP)

In-Kind Grants of Training and Mentorship Related to Lymphoma
Research to USA and Canada Fellows and Junior Faculty Members

Agency Type:

Foundation / Corporation

Funding Source:

Add to My Calendar 

Lymphoma Research Foundation (LRF)

Deadline Date:

09/05/19 5:00 PM EST

Description:

Request a Grant Writer

In-kind grants of mentoring, training, and medical education to USA and Canada hematology and oncology fellows and junior faculty members for research related to lymphoma. Grants are intended for participation in a two-year program that provides education related to clinical research and career development, as well as career management and quality-of-life issues. The Foundation considers “lymphoma” to encompass all recognized lymphoma subtypes as well as chronic lymphocytic leukemia (CLL).

The goals of the LCRMP include:
- Provide mentoring and education to hematology/oncology fellows and junior faculty. The program will emphasize training in clinical research methods and design, statistical analysis, pathology, incorporating and interpreting correlative studies into clinical trials, and grant submission and funding. The program also aims to foster mentorship and research collaboration among experts and trainees in the field.
- Assist in the development of a specific clinical trial in patients with lymphoma and to set the foundation for grant development to support the trial. Study design and implementation will be discussed in a small group setting consisting of experts in the field, statisticians, and other trainees in the program, where information, ideas, guidance, support and connections are shared, and where mentoring relationships can be developed.
- Provide continuing training, career development advice, and mentorship among trainees and experts in the field and to foster future participation and collaboration within the LRF through follow-up programming and activities.

LRF Scholars attend an initial LCRMP workshop, which is four days in length. LRF will convene a faculty of experts in lymphoma clinical research who will share their experience and knowledge throughout the program with the Scholars as a group and in small breakout groups. Faculty participating in the small groups and serving as mentors for the program will remain for the entirety of the program. Faculty not only mentor Scholars at the workshop but will also be available to Scholars post-workshop. In addition, a handful of select presenters with specific knowledge for the didactic sessions or who have successfully obtained LRF
grants will attend at least a portion of the program to present selected topics or to provide training in grant development and submission.

The workshop will consist of Scholars presenting their proposed clinical research projects, attending the content sessions, working with Mentors including a statistician, revising their proposed clinical studies and developing Specific Aims for a future grant submission, and presenting the revised protocol and Specific Aims of future grants at the completion of the workshop. In addition to the workshop, scholars will be supported throughout the following year by program faculty and LRF staff. In addition, scholars will attend two meetings (tentatively scheduled for October 2019 and 2020) in order to participate in LRF scientific meetings and mock grant review exercises.

For information about the program curriculum, and additional scholar activities, see:
https://www.lymphoma.org/wp-content/uploads/2019/05/LCRMP-RFP-2020-.pdf#page=2

GrantWatch ID#:

GrantWatch ID#: 186436

Number of Grants:

The LRF Scientific Advisory Board will select up to 8 applicants.

Term of Contract:

The workshop will take place March 3-7, 2020.

Additional Eligibility Criteria:

Applicant Eligibility:
1. Applicants must demonstrate a clear interest and commitment to a career in lymphoma clinical research. This commitment to a career focused on lymphoma-related research should be reflected in the applicant’s career
development plan and in the letter of support provided by their mentor.
2. Applicants for this award must be a junior faculty member in their first four years of a faculty position or trainees who are at least in their second year of one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, Pediatric Hematology/Oncology, or Hematopathology. Applicants should not be more than four years beyond completion if their fellowship or more than twelve years beyond completion of their MD or equivalent degree.
3. Applicants must be affiliated with a sponsoring institution in the U.S. or Canada for the duration of the LCRMP award. Citizenship is not required.
4. Applicants should not be participating in another competitively applied for mentorship (such as ASH’s CRTI) during the LCRMP period (March 2020 through October 2022). Applicants who will have completed other mentorship programs prior to March 2020 are welcome.
5. Selected applicants are required to attend and participate in all LCRMP programs in their entirety including the 2020 workshop, follow-up programs (Fall 2020 and 2021), and LRF required communication, reporting, and evaluation.
6. Fluency in English.
7. Studies or proposals that are exclusively laboratory based are not appropriate for the LRF LCRMP. Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic methods, therapies, and/or outcome measurements directed to patients with lymphoma are required.
8. All applicants must have an identified Primary Mentor at their home institution who is willing and able to provide financial support for the project and demonstrate a commitment to completing the proposal in order to ensure feasibility of the proposal. Associate Mentors, who may provide support for additional aspects of the project and be based at other institutions, are welcome but not a requirement.
9. LCRMP applications are self-initiated. LRF does not invite applications from selected individuals, institutions, or laboratories.

Pre-Application Information:

The application deadline is 5:00 PM EST, September 5, 2019. Applications should be submitted through proposedCENTRAL.

To avoid being rushed at deadline time, applicants are encouraged to register and complete a professional profile at proposalCENTRAL now. Applicants should make sure their grants and contracts office has registered their institution and signing officials with proposalCENTRAL, and that they acquaint themselves with any internal approval processes required by their institution’s grant office.

Key Dates:
- Application Release Date: May 31, 2019
- Application Deadline: September 5, 2019 at 5:00 PM EST
- Peer Review Process: September – November 2019
- Applicant Notification Date: December 2019
- Workshop Dates: March 3 - 7, 2020, in Scottsdale, AZ

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Apply online: https://proposalcentral.com/ProposalGI.asp?SectionID=2315&ProposalID=-1

For technical support:
Phone: 800-875-2562(Toll free) or 703-964-5840
E-mail: pcsupport@altum.com

Foundation contact:
Whitney Steen, Senior Manager, Research Grants and Communications
Phone: 212-349-2910
researchgrants@lymphoma.org

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming

Canada: Alberta   British Columbia   Manitoba   New Brunswick   Newfoundland and Labrador   Northwest Territories   Nova Scotia   Nunavut   Ontario   Prince Edward Island   Quebec   Saskatchewan   Yukon